These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7011049)

  • 41. Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal.
    Dicostanzo CA; Dardevet DP; Neal DW; Lautz M; Allen E; Snead W; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E9-E16. PubMed ID: 16105863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery.
    Moore MC; Burish MJ; Farmer B; Neal DW; Pan C; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E845-53. PubMed ID: 12773306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Control of hepatic glucose output by glucagon and insulin in the intact dog.
    Cherrington AD; Chiasson JL; Liljenquist JE; Lacy WW; Park CR
    Biochem Soc Symp; 1978; (43):31-45. PubMed ID: 373768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Splanchnic glucagon kinetics in exercising alloxan-diabetic dogs.
    Coker RH; Lacy DB; Krishna MG; Wasserman DH
    J Appl Physiol (1985); 1999 May; 86(5):1626-31. PubMed ID: 10233127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of the hepatic artery in the metabolism of phenacetin and acetaminophen: intravital microscopic and multiple-indicator dilution study in perfused rat liver.
    Pang KS; Sherman IA; Schwab AJ; Geng W; Barker F; Dlugosz JA; Cuerrier G; Goresky CA
    Hepatology; 1994 Sep; 20(3):672-83. PubMed ID: 8076925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions.
    Kuan HY; Smith DE; Ensmiger WD; Knol JA; DeRemer SJ; Yang Z; Stetson PL
    Cancer Res; 1996 Oct; 56(20):4724-7. PubMed ID: 8840990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon.
    Shulman GI; Liljenquist JE; Williams PE; Lacy WW; Cherrington AD
    J Clin Invest; 1978 Aug; 62(2):487-91. PubMed ID: 670404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between arterial and portal vein immunoreactive glucagon during exercise.
    Wasserman DH; Lacy DB; Bracy DP
    J Appl Physiol (1985); 1993 Aug; 75(2):724-9. PubMed ID: 8226475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin's direct effects on the liver dominate the control of hepatic glucose production.
    Edgerton DS; Lautz M; Scott M; Everett CA; Stettler KM; Neal DW; Chu CA; Cherrington AD
    J Clin Invest; 2006 Feb; 116(2):521-7. PubMed ID: 16453026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of the endocrine pancreas in the kalemic response to acute metabolic acidosis in conscious dogs.
    Adrogué HJ; Chap Z; Ishida T; Field JB
    J Clin Invest; 1985 Mar; 75(3):798-808. PubMed ID: 3884666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased uptake of insulin and glucagon by the liver as a signal for regeneration.
    Caruana JA; Gage AA
    Surg Gynecol Obstet; 1980 Mar; 150(3):390-4. PubMed ID: 6986667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs.
    Nishizawa M; Moore MC; Shiota M; Gustavson SM; Snead WL; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E1027-36. PubMed ID: 12569088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration.
    Myers SR; McGuinness OP; Neal DW; Cherrington AD
    J Clin Invest; 1991 Mar; 87(3):930-9. PubMed ID: 1999501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperinsulinemia compensates for infection-induced impairment in net hepatic glucose uptake during TPN.
    Donmoyer CM; Chen SS; Hande SA; Lacy DB; Ejiofor J; McGuinness OP
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E235-43. PubMed ID: 10913021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The direct effects of catecholamines on hepatic glucose production occur via alpha(1)- and beta(2)-receptors in the dog.
    Chu CA; Sindelar DK; Igawa K; Sherck S; Neal DW; Emshwiller M; Cherrington AD
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E463-73. PubMed ID: 10913048
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of hepatic insulin influx on insulin retention: comparison of net flux and per cent extraction as indices of hepatic insulin retention.
    Wieczorek KR; Rajotte RV; Molnar GD; McGregor JR; Lussier BT; Fawcett DM
    Clin Invest Med; 1985; 8(4):257-63. PubMed ID: 2866858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic and renal metabolism of somatostatin-like immunoreactivity. Simultaneous assessment in the dog.
    Polonsky KS; Jaspan JB; Berelowitz M; Emmanouel DS; Dhorajiwala J
    J Clin Invest; 1981 Nov; 68(5):1149-57. PubMed ID: 6117570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetic approach to the estimation of hepatic removal of insulin.
    Berzins R; Tam YK; Molnar GD; Rajotte RV; Wieczorek KR; McGregor JR; Fawcett DM
    Pancreas; 1986; 1(6):544-9. PubMed ID: 3550790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Secretory patterns of glucoregulatory hormones in prehepatic circulation of dogs.
    Sirek A; Vaitkus P; Norwich KH; Sirek OV; Unger RH; Harris V
    Am J Physiol; 1985 Jul; 249(1 Pt 1):E34-42. PubMed ID: 2861748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of hepatic insulin extraction from in vivo surrogate methods of insulin clearance measurement.
    Asare-Bediako I; Paszkiewicz RL; Kim SP; Woolcott OO; Kolka CM; Burch M; Kabir M; Piccinini F; Bergman RN
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E605-E612. PubMed ID: 29509434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.